John Leonard

John Leonard has over 20 years of experience in the pharmaceutical industry. John is currently the President and CEO of Intellia Therapeutics. Previously, they served as a Board Member for Vitae Pharmaceuticals and Chimerix, Inc. John also held the position of Senior Vice President of Global Pharmaceutical Research and Development for AbbVie and Abbott. John Leonard has a proven track record of success in the pharmaceutical industry and is dedicated to improving the lives of patients through innovative treatments.

John Leonard first attended the University of Wisconsin-Madison where they obtained their Bachelor of Arts in Biochemistry. John then attended The Johns Hopkins University where they obtained their Doctor of Medicine (MD). After completing their medical degree, they completed an Internal Medicine Residency Program at Stanford University School of Medicine. John is currently a Post-Doctoral Fellow in Molecular Virology at the National Institutes of Health.

Some direct reports include Yuanxin Xu - SVP, Early Development & Transitional Medicine, Laura Sepp-Lorenzino - EVP, Chief Scientific Officer, and Aron Stein - SVP, Regulatory Affairs.